April 13, 2023 For the second time in less than a year, Arizona State University Center for the Advancement of…
win
![Teva and Viatris win US appeal in Parkinson's disease drug patent fight; Novavax Cut Costs by $50 Million, Plans to Cut More, CEO Says, and More [Beuzz] 2 Teva and Viatris win US appeal in Parkinson's disease drug patent fight; Novavax Cut Costs by $50 Million, Plans to Cut More, CEO Says, and More](https://beuzz.club/wp-content/uploads/2023/04/Teva-and-Viatris-win-US-appeal-in-Parkinsons-disease-drug.jpeg)
Teva and Viatris win US appeal in Parkinson’s disease drug patent fight; Novavax Cut Costs by $50 Million, Plans to Cut More, CEO Says, and More [Beuzz]
Here is a summary of health news briefs. Teva and Viatris win US appeal in Parkinson’s disease drug patent fight…